Tylenol Autism Lawsuit 2026: 500+ Cases Revived

Jonas Hill - 2026-07-22

The Tylenol autism lawsuit involves claims that prenatal exposure to acetaminophen, the active ingredient in Tylenol and many generic pain relievers, may be associated with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children.

The federal litigation is consolidated in MDL No. 1:22-md-3043, formally known as In re: Acetaminophen – ASD-ADHD Products Liability Litigation, in the U.S. District Court for the Southern District of New York. The cases are before U.S. District Judge Denise L. Cote. The official MDL 3043 court page provides information about the litigation and its court filings.

A major development occurred in July 2026, when the U.S. Court of Appeals for the Second Circuit reversed portions of the district court's earlier rulings involving plaintiffs' expert testimony. The decision revived more than 500 federal lawsuits, allowing the litigation to continue. However, the ruling did not establish that Tylenol or acetaminophen causes autism or ADHD.

The scientific evidence concerning prenatal acetaminophen exposure remains disputed. There is also no confirmed nationwide Tylenol autism lawsuit settlement or court-approved compensation fund as of September 2026.

Tylenol Autism Lawsuit: Key Takeaways

The federal litigation is known as MDL 3043.
Plaintiffs allege that prenatal exposure to acetaminophen contributed to ASD and/or ADHD.
The lawsuits include allegations that manufacturers and retailers failed to adequately warn consumers about alleged risks.
The federal litigation began in 2022.
Plaintiffs' expert testimony became a central issue in the case.
In December 2023, the district court excluded plaintiffs' general-causation experts.
Additional expert testimony was excluded in 2024.
In July 2026, the Second Circuit reversed portions of those rulings and revived more than 500 federal lawsuits.
The appellate decision did not conclude that acetaminophen causes autism or ADHD.
Scientific research on the issue remains contested.
There is currently no confirmed nationwide settlement or guaranteed payout.
Potential claimants should preserve relevant medical and exposure records and speak with a qualified attorney about their circumstances.

What Is the Tylenol Autism Lawsuit?

The Tylenol autism lawsuit refers to litigation involving allegations concerning prenatal exposure to acetaminophen and neurodevelopmental conditions such as autism spectrum disorder and ADHD.

Plaintiffs generally allege that mothers used Tylenol or other acetaminophen-containing products during pregnancy and that their children later developed ASD, ADHD, or related neurodevelopmental conditions.

The lawsuits primarily raise product-liability and failure-to-warn allegations. Plaintiffs argue that manufacturers and retailers should have provided additional warnings concerning potential risks associated with prenatal acetaminophen exposure.

The federal court's description of MDL 3043 states that plaintiffs allege children developed ASD and/or ADHD as a result of in-utero exposure to acetaminophen.

It is important to distinguish an allegation from a proven medical or legal finding. The filing of a lawsuit does not establish that acetaminophen caused a particular child's condition.

For readers interested in the broader litigation involving Tylenol, including other allegations and legal issues, see our Tylenol lawsuit guide.

What Is Acetaminophen?

Acetaminophen is the active ingredient found in Tylenol and many other prescription and over-the-counter medications.

It is commonly used to reduce fever and relieve pain.

Tylenol is a brand name, while acetaminophen is the drug's active ingredient. As a result, litigation involving acetaminophen can involve products that are not sold under the Tylenol brand.

This distinction is important because a person may have used a generic or store-brand acetaminophen product rather than a Tylenol-branded medication.

The U.S. Food and Drug Administration continues to monitor acetaminophen safety, including its use during pregnancy. The FDA currently advises people to discuss medication use during pregnancy with a healthcare professional. Its current acetaminophen and pregnancy information says the agency has not found clear evidence that appropriate acetaminophen use during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes.

Why Are People Filing Tylenol Autism Lawsuits?

The lawsuits focus on allegations concerning prenatal exposure to acetaminophen and possible neurodevelopmental effects.

Plaintiffs argue that manufacturers and retailers knew or should have known about research examining possible associations between prenatal acetaminophen exposure and conditions such as ASD and ADHD.

The litigation therefore raises several questions, including:

Can prenatal acetaminophen exposure cause ASD or ADHD?
Was there sufficient scientific evidence to justify additional warnings?
When did manufacturers allegedly know about potential risks?
Were consumers adequately warned?
Can plaintiffs establish general causation?
Can plaintiffs establish specific causation?
Are certain claims affected by federal preemption?
Which companies may be legally responsible for a particular product?

These legal questions are separate from whether acetaminophen can be useful for treating pain or fever.

What Is MDL 3043?

MDL 3043 is the federal multidistrict litigation involving acetaminophen and alleged ASD and ADHD claims.

Its formal name is:

In re: Acetaminophen – ASD-ADHD Products Liability Litigation.

The litigation is pending in the U.S. District Court for the Southern District of New York before Judge Denise L. Cote. The MDL was established in October 2022.

Multidistrict litigation allows federal cases involving common factual questions to be coordinated before one federal court for pretrial proceedings. It is different from a traditional class action.

In MDL 3043, the cases involve overlapping questions concerning prenatal acetaminophen exposure, scientific evidence, alleged health effects, warnings and product liability.

One of the most important issues has been general causation.

General causation asks whether prenatal acetaminophen exposure can generally cause ASD or ADHD.

Specific causation is different. It concerns whether the alleged exposure actually caused the condition in an individual child.

Tylenol Autism Lawsuit Timeline

2022: Federal MDL Is Established

Federal lawsuits involving similar allegations were centralized in the Southern District of New York in 2022.

The cases raised common questions concerning prenatal acetaminophen exposure and alleged neurodevelopmental effects.

The Judicial Panel on Multidistrict Litigation transferred the cases for coordinated proceedings.

2023: Expert Evidence Becomes a Major Issue

Scientific evidence became one of the central issues in the litigation.

Because plaintiffs' claims depended heavily on evidence concerning whether prenatal acetaminophen exposure could cause ASD or ADHD, both sides presented expert opinions concerning epidemiological research and causation.

December 2023: Plaintiffs' General-Causation Experts Are Excluded

In December 2023, Judge Cote granted defendants' motions to exclude the opinions of plaintiffs' general-causation experts.

The court concluded that plaintiffs did not have admissible expert evidence establishing that prenatal acetaminophen exposure causes ASD or ADHD. The court's December 2023 expert-evidence opinion provides the detailed reasoning behind that decision.

The decision was a significant setback for plaintiffs because expert testimony was central to their causation arguments.

2024: Additional Expert Testimony Is Excluded

Another plaintiff expert, Dr. Roberta Ness, was also excluded from providing a general-causation opinion in July 2024.

The district court's ruling further complicated the plaintiffs' ability to establish the scientific evidence needed for their claims.

2026: Second Circuit Revives Federal Lawsuits

The litigation changed significantly in July 2026.

The U.S. Court of Appeals for the Second Circuit reviewed the district court's decisions concerning plaintiffs' expert witnesses.

The appeals court reversed portions of the lower court's rulings and allowed three of the plaintiffs' five general-causation experts to remain in the litigation.

The decision revived more than 500 federal lawsuits that had previously been dismissed.

The ruling was an important procedural victory for plaintiffs, but it did not determine that acetaminophen causes autism or ADHD.

What Did the Second Circuit Decide in 2026?

The July 2026 Second Circuit decision is one of the most important developments in the Tylenol autism litigation.

The appellate court examined whether the district court had properly handled the admissibility of plaintiffs' expert testimony under Federal Rule of Evidence 702.

The court reinstated three experts while leaving two experts excluded.

The practical effect was to revive the federal litigation and allow plaintiffs another opportunity to present their scientific evidence.

However, the ruling should not be interpreted as a finding that Tylenol causes autism.

The appellate decision did not:

Establish that Tylenol causes autism.
Establish that acetaminophen causes ADHD.
Award compensation to plaintiffs.
Create a nationwide settlement.
Guarantee that plaintiffs will win their cases.
Establish eligibility for everyone who used Tylenol during pregnancy.

Instead, the ruling allows the litigation to proceed so that the scientific evidence can continue to be evaluated.

Does Tylenol Cause Autism?

There is currently no court ruling establishing that Tylenol causes autism.

The scientific evidence is also not settled.

Some observational studies have reported an association between prenatal acetaminophen exposure and neurodevelopmental outcomes. Other research has questioned whether acetaminophen itself causes those conditions.

The distinction between association and causation is particularly important.

An association means researchers observe that two things occur together more often than expected. It does not necessarily mean that one caused the other.

Researchers must also consider potential confounding factors, differences in study design, exposure measurement, dose, timing and other variables.

The FDA has acknowledged that studies have reported a possible association between acetaminophen use during pregnancy and autism and ADHD. However, the agency has also stated that a causal relationship has not been established and that contrary scientific evidence exists.

Therefore, it would be inaccurate to state that medical science or the courts have established that Tylenol causes autism.

What Does the FDA Say About Tylenol and Autism?

The FDA has taken several steps concerning the scientific evidence surrounding acetaminophen use during pregnancy.

In September 2025, the FDA announced that it was initiating a process to change acetaminophen labeling to reflect evidence suggesting that acetaminophen use during pregnancy may be associated with an increased risk of neurological conditions such as autism and ADHD in children.

However, the FDA also emphasized that a causal relationship has not been established and that contrary scientific evidence exists.

The agency's position therefore requires careful interpretation.

The FDA's current acetaminophen information continues to state that it has not found clear evidence that appropriate acetaminophen use during pregnancy causes adverse developmental outcomes.

These statements illustrate why the issue remains scientifically and legally contested.

What Does Scientific Research Say?

Scientific research is at the center of the Tylenol autism lawsuit.

Researchers have used observational studies, cohort studies and other epidemiological methods to examine prenatal acetaminophen exposure.

Some studies have reported an association between prenatal exposure and neurodevelopmental outcomes.

However, observational research can have limitations.

For example, researchers must consider whether other factors associated with acetaminophen use during pregnancy could also affect a child's development.

Potential confounding factors are therefore an important part of the debate.

The litigation has focused heavily on how experts interpreted the available research and whether their methodologies were sufficiently reliable for use in court.

The 2023 district court opinion demonstrates how extensively these scientific disagreements were examined during the expert-evidence proceedings.

Who Are the Defendants in the Tylenol Autism Lawsuit?

The federal litigation includes claims involving manufacturers and retailers connected with acetaminophen products.

Depending on the particular lawsuit, defendants may include companies involved in:

Manufacturing acetaminophen products
Marketing acetaminophen products
Selling Tylenol
Selling generic acetaminophen
Retailing acetaminophen-containing products

The specific defendants can vary between cases.

A person should therefore not assume that every company selling acetaminophen is automatically a defendant in every Tylenol autism lawsuit.

The product involved, manufacturer, retailer, location, applicable law and allegations can all affect which companies are named.

Who May Qualify for a Tylenol Autism Lawsuit?

Potential eligibility depends on the facts of an individual case.

An attorney evaluating a possible claim may consider:

Whether acetaminophen was used during pregnancy
When during pregnancy it was used
How frequently it was used
The approximate duration of use
Which product was taken
Whether the child has an ASD or ADHD diagnosis
The child's medical history
The mother's medical and pregnancy history
Available medical records
Pharmacy records
Applicable state law
The statute of limitations

Taking Tylenol during pregnancy does not automatically establish eligibility for a lawsuit.

Similarly, an autism or ADHD diagnosis does not by itself establish that prenatal acetaminophen exposure caused the condition.

A qualified attorney would need to evaluate the specific facts and applicable law.

What Evidence May Be Needed?

People considering a potential claim should preserve relevant documentation.

Medical Records

Pregnancy records may help establish medical history, medication use and the timing of exposure.

Pharmacy Records

Pharmacy records can potentially help establish purchases or prescriptions involving acetaminophen.

Product Information

If available, information about the product, manufacturer, dosage and formulation may be useful.

Child's Medical Records

Diagnostic and treatment records can establish the child's diagnosis and medical history.

Exposure Timeline

A written record describing when acetaminophen was used, how frequently it was used and why it was taken may help an attorney understand the circumstances.

Evidence does not automatically establish causation, but it can help determine whether a potential legal claim warrants further investigation.

Is There a Tylenol Autism Lawsuit Settlement?

As of September 2026, there is no confirmed nationwide Tylenol autism lawsuit settlement or court-approved compensation fund for the federal MDL.

The July 2026 Second Circuit ruling revived the litigation but did not establish a settlement or award damages.

Readers should therefore be cautious about websites or advertisements promising guaranteed Tylenol autism lawsuit payouts.

There is currently no reliable basis for stating that every eligible claimant will receive a particular amount.

How Much Is a Tylenol Autism Lawsuit Worth?

There is currently no fixed or guaranteed payout amount.

Because the litigation remains ongoing and there is no nationwide settlement establishing compensation, online claims about specific guaranteed payouts should be treated cautiously.

The potential value of an individual case can depend on:

The strength of the evidence
Proof of acetaminophen exposure
Medical evidence
Causation
The severity and nature of damages
Applicable state law
Medical and future-care expenses
Liability

The outcome of future litigation or settlement negotiations

A lawyer cannot guarantee a particular recovery based solely on exposure to acetaminophen and an autism or ADHD diagnosis.

Has Anyone Won a Tylenol Autism Lawsuit?

The federal MDL has not produced a trial verdict establishing that prenatal acetaminophen exposure caused autism or ADHD and awarding damages to plaintiffs.

The July 2026 Second Circuit decision was also not a final ruling on causation.

Instead, it addressed the admissibility of expert testimony and allowed the federal litigation to move forward.

The underlying scientific and legal questions therefore remain unresolved.

Are There Tylenol Autism Lawsuits Outside MDL 3043?

Yes.

Not every lawsuit involving acetaminophen is necessarily part of the federal MDL.

State-court litigation can proceed separately under state law. The federal MDL covers a particular group of coordinated federal cases and does not automatically include every claim involving acetaminophen.

State laws can also differ regarding:

Product-liability claims
Failure-to-warn claims
Statutes of limitations
Evidence requirements
Available damages
Who may be sued

Anyone considering a potential claim should determine which jurisdiction applies to their circumstances.

What Happens Next in the Tylenol Autism Lawsuit?

Following the July 2026 appellate decision, the federal litigation returns to the Southern District of New York for further proceedings.

Future proceedings may address:

Reinstated expert testimony
Additional expert disputes
General causation
Further discovery
Case-specific causation
Motions filed by the parties
Potential bellwether cases
Possible settlement discussions

A bellwether trial is generally used in multidistrict litigation to help the court and parties evaluate how particular claims, evidence and legal arguments may perform at trial.

A bellwether verdict would not automatically determine the outcome of every individual lawsuit.

The official Southern District of New York MDL page remains the best place to monitor official court information and filings.

What Should You Do If You Think You Have a Claim?

If you believe you may have a potential Tylenol autism lawsuit, consider preserving relevant records.

You may want to:

Gather pregnancy and medical records.
Obtain available records concerning acetaminophen use.
Keep your child's diagnostic and treatment records.
Write down approximate dates and frequency of medication use.
Identify the product or products used, if possible.
Keep available information about where the product was purchased.
Determine the applicable statute of limitations.
Speak with an attorney experienced in pharmaceutical or product-liability litigation.

Do not assume that an online advertisement, questionnaire or eligibility form establishes that you have a valid legal claim.

Tylenol Lawsuit vs. Tylenol Autism Lawsuit

The terms can sometimes be used interchangeably online, but they cover different search intents.

A broad Tylenol lawsuit page can discuss multiple types of allegations involving acetaminophen, including product safety, liver injury and other litigation.

The Tylenol autism lawsuit focuses specifically on prenatal acetaminophen exposure and allegations involving ASD and ADHD.

For the broader legal picture, readers can visit our Tylenol lawsuit guide.

This page focuses specifically on MDL 3043, the scientific evidence, prenatal exposure, eligibility, settlement status and the latest developments in the autism-related litigation.

Frequently Asked Questions

Is the Tylenol autism lawsuit still active in 2026?

Yes. The federal litigation continues after the Second Circuit's July 2026 decision reversed portions of the district court's expert-evidence rulings and revived more than 500 federal cases.

What is MDL 3043?

MDL 3043 is the federal multidistrict litigation titled In re: Acetaminophen – ASD-ADHD Products Liability Litigation. It is pending in the Southern District of New York before Judge Denise L. Cote.

Does Tylenol cause autism?

A causal relationship has not been established. Some studies have reported an association between prenatal acetaminophen exposure and neurodevelopmental outcomes, while other research has raised questions about causation and potential confounding factors. The FDA has stated that a causal relationship has not been established.

Can taking Tylenol during pregnancy qualify someone for a lawsuit?

Not automatically. Potential eligibility depends on factors including exposure, timing, diagnosis, medical evidence, applicable law and filing deadlines.

Is there a Tylenol autism lawsuit settlement?

There is no confirmed nationwide settlement or court-approved compensation fund for MDL 3043 as of September 2026.

How much is a Tylenol autism lawsuit worth?

There is no established payout amount. Any specific nationwide payout figure would be speculative while the litigation remains unresolved.

Can someone sue if they used generic acetaminophen instead of Tylenol?

Potentially. The litigation concerns acetaminophen products, not exclusively products carrying the Tylenol brand. However, the specific product, manufacturer, retailer and applicable law can affect a potential claim.

What evidence is needed for a Tylenol autism lawsuit?

Potentially relevant evidence includes pregnancy medical records, pharmacy records, product information, evidence of acetaminophen exposure and the child's medical and diagnostic records.

Has a court ruled that Tylenol causes autism?

No. The July 2026 appellate ruling concerned expert testimony and the continuation of litigation. It did not determine that acetaminophen causes autism or ADHD.

Where can I find official information about MDL 3043?

The U.S. District Court for the Southern District of New York maintains the official MDL 3043 information page, which provides information about the litigation and links to relevant court dockets.

Bottom Line

The Tylenol autism lawsuit remains an evolving area of product-liability litigation.

The most significant recent development was the Second Circuit's July 2026 decision, which reversed portions of the district court's expert-evidence rulings and revived more than 500 federal lawsuits.

However, the decision did not establish that prenatal acetaminophen exposure causes autism or ADHD. Instead, it allows plaintiffs to continue presenting their scientific evidence as the litigation moves forward.

The FDA has acknowledged evidence suggesting a possible association between acetaminophen use during pregnancy and autism or ADHD while also stating that a causal relationship has not been established.

There is currently no confirmed nationwide settlement or guaranteed compensation amount.

For people researching a potential claim, the most important steps are to understand the current litigation, preserve relevant medical and exposure records, and obtain advice based on the specific facts and applicable law.

This article is for general informational purposes only and does not constitute legal or medical advice.

Tylenol Autism Lawsuit 2026: MDL 3043, Latest Updates, Eligibility and Settlement